Cargando…
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
Atrial fibrillation and coronary artery disease are commonly coexisting conditions that necessitate the use of an oral anticoagulant as well as dual antiplatelet therapy. Commonly referred to as triple oral antithrombotic therapy (TT), this helps prevent ischemic stroke and myocardial infarction but...
Autores principales: | Moustafa, Abdelmoniem, Ruzieh, Mohammad, Eltahawy, Ehab, Karim, Saima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796304/ https://www.ncbi.nlm.nih.gov/pubmed/31903386 http://dx.doi.org/10.4103/ajm.AJM_73_19 |
Ejemplares similares
-
Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
por: Wei, Lili, et al.
Publicado: (2020) -
Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: A meta-analysis
por: Moustafa, Abdelmoniem, et al.
Publicado: (2020) -
Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease
por: Chan, Pak Hei, et al.
Publicado: (2015) -
Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
por: Bor, Wilbert, et al.
Publicado: (2020) -
Challenges in Treatment of Inappropriate Sinus Tachycardia
por: Ruzieh, Mohammed, et al.
Publicado: (2018)